Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 5 ... possibility in the current study, using the ARBs olmesartan, valsartan, losartan, and telmisartan. Plasma, renal, and cardiac levels of CGRP and IGF-I in SHRs were significantly lower ...
2009 NOV 2 ... New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis=AE (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from ...
2009 NOV 2 ... allocated to treatment with simvastatin 20 mg/day for 2 weeks, then randomly assigned to telmisartan (40-80 mg/day) or bisoprolol (5-10 mg/day). After 4 weeks the antihypertensive drugs ...
2009 NOV 23 ... h with increased doses of the following drugs: hydrochlorothiazide, atenolol, losartan, telmisartan, captopril, and nifedipine. Adiponectin levels, as well as adiponectin-mRNA expression, ...
2009 SEP 15 ... "The relevance of substituents at C-2 of the central benzimidazole of telmisartan for PPAR gamma activation has recently been demonstrated, and the most active compound ...
2009 OCT 19 ... ambulatory BP similar to 148/93 mm Hg) randomized to the angiotensin receptor blocker, telmisartan (80 mg; n = 802), or the angiotensin-converting enzyme inhibitor, ramipril (5 or 10 mg; ...
2009 NOV 9 ... of Alzheimer disease is deposition of amyloid-beta protein (A beta) in the brain. Telmisartan is a unique angiotensin II receptor blocker with peroxisome proliferator-activated ...
2009 AUG 31 ... renal effects in other patients are not clear. To examine the long-term renal effects of telmisartan versus placebo in adults at high vascular risk. Randomized trial." "were ...
2009 SEP 7 ... New investigation results, 'The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model,' are detailed in a ...
2009 SEP 21 ... the effects of sodium chloride (NaCl) supplementation on the antialbuminuric action of telmisartan with or Without hydrochlorothiazide (HCT) in hypertensive patients with type 2 diabetes, ...
2009 OCT 5 ... blocker metoprolol (MET), the angiotensin II type I (AT1)-receptor antagonist telmisartan (TEL) or an antibody blocking TGF-beta1 signalling (TGFbeta1-sR-Ab). Transforming growth ...
2009 OCT 5 ... (ACE-I) (ie, aldosterone breakthrough). The angiotensin II receptor blocker (ARB) telmisartan can function as a ligand for peroxisome proliferator-activated receptor (PPAR) gamma," ...
2009 NOV 16 ... in high-risk patients without heart failure is unknown." "In the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET), patients at ...
2009 OCT 5 ... several reports on combination strategies. However, the recent report of the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) has received ...
2009 AUG 24 ... TRANSCEND clinical trials were designed to investigate the cardioprotective effects of telmisartan 80 mg and ramipril 10 mg, alone and in combination, in patients at high risk of ...
2009 AUG 24 ... with cardiac diseases. We examined the effects of an angiotensin II receptor blocker, telmisartan, on cardiac remodeling in renovascular hypertensive rats," scientists in Tokyo, Japan ...
2009 JUL 20 ... Fresh data on alcoholism are presented in the report 'Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage ...
2009 AUG 24 ... populations has been demonstrated by two recently completed major trials: the Ongoing Telmisartan Alone and in Combination with Ramipril Global endpoint Trial (ONTARGET) and the...
2009 JUN 29 ... mesenteric arteries and angiotensin II in aortas. Long-term (8 weeks) administration of telmisartan, an angiotensin II type 1-receptor antagonist, prevented the impaired vasorelaxation, ...
2009 AUG 31 ... Current study results from the report, 'Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial,' have been published. ...
